Cue Biopharma, Inc. (CUE) Insider Trading Disclosures
Cue Biopharma, Inc. (CUE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CUE
CIK: 1645460
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerDaniel Gaffey
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-14 | 2026-10-12 | 4 Filing | 0001579629-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-12 | 4 Filing | 0002138368-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-12 | 4 Filing | 0001725092-26-000019 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001725092-26-000017 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001579629-26-000010 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-08 | — | SCHEDULE 13G/A Filing | 0001213900-26-107721 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-20 | 8-K | 0001193125-26-396094 | View SEC Doc Filr Page |
| 4/A | 2026-08-28 | 2026-07-09 | 4/A Filing | 0002059447-26-000006 | View SEC Doc Filr Page |
| 4/A | 2026-08-28 | 2026-07-09 | 4/A Filing | 0001974756-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-21 | — | SCHEDULE 13D Filing | 0001725092-26-000015 | View SEC Doc Filr Page |
| EFFECT | 2026-08-20 | — | EFFECT Filing | 9999999995-26-002724 | View SEC Doc Filr Page |
| CORRESP | 2026-08-18 | — | CORRESP Filing | 0001193125-26-355392 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001579629-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0002138368-26-000007 | View SEC Doc Filr Page |
| UPLOAD | 2026-08-17 | — | UPLOAD Filing | 0000000000-26-008092 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | 4 Filing | 0001725092-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001725092-26-000011 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-352128 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001193125-26-352126 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000938206-26-000041 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001579629-26-000006 | View SEC Doc Filr Page |
| S-3 | 2026-08-12 | — | S-3 | 0001193125-26-346867 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-07-27 | 8-K | 0001193125-26-330730 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 Filing | 0001320383-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-07-30 | 3 Filing | 0001320383-26-000004 | View SEC Doc Filr Page |